Awor, please clarify this : are you telling people here that they could take “antifungals” for their supposed HDACi properties? Which antifungals are you talking about? Are you saying that “antifungals” as a whole are HDACi? If so, where did you get this info from? Please provide some proof. I actually know for a fact that this is wrong.
HDAC inhibitors (at least class I and II) are in effect antifungals (HDAC inhibition has by itself antifungal effects), but the reverse is not true. viewtopic.php?p=53666#p53666
Trichostatin A, a well known, potent HDACi (probably the strongest), is therefore a strong antifungal. Its antifungal property was known first, then its HDACi -hence anti-cancer - effect was discovered, which is actually the main reason for its antifungal effect.
Niacinamide, butyrate and other HDAC inhibiting compounds have recently been investigated for their antifungal activity. Recent studies show how HDACi potentiate the antifungal effects of azoles (which are NOT HDACi) and highlight their interest in new antifungal strategies.
Nystatin also has NO HDACi properties. Proof here : biomedcentral.com/content/pdf/ar1702.pdf (thanks to 2nd amendment for providing the link). Its safe to say that the very similar polyene amphotericin B isnt an HDACi either.
Amphotericin B, Nystatin, azoles have no HDAC inhibiting properties… Which antifungals are you referring too then? Trichostatin A is the only well known HDACi that I know of that has always been used as an antifungal first and foremost.
I also read that you’ve been saying that in addition to antifungals, “just about all antibiotics”, have HDACi properties. Please clarify which ones because commonly used one such as penicillin, streptomycin, and gentamicin have NO HDACi properties worth speaking of as the study kindly provided by 2nd amendment shows us (unless the study was conducted by complete morons).
edit : added a GREAT article on (safe) dietary epigenetics modulators for those interested
Nature or nurture Let food be your epigenetic medicine in chronic inflammatory disorders.pdf (606 KB)